5-time Grand Slam Champion Iga Swiatek Accepts One-Month Suspension in Doping Case

5-time Grand Slam Champion Iga Swiatek Accepts One-Month Suspension in Doping Case
Poland's Iga Swiatek returns the ball against Italy's Jasmine Paolini during the Billie Jean King Cup semi-final tennis match at Martin Carpena Sports Hall in Malaga, southern Spain, on Nov. 18, 2024. Manu Fernandez/AP Photo
The Associated Press
Updated:
0:00

Five-time Grand Slam champion Iga Swiatek accepted a one-month suspension after testing positive for the banned substance trimetazidine, a heart medication known as TMZ, the International Tennis Integrity Agency announced Thursday.

Swiatek failed an out-of-competition drug test in August, and the ITIA accepted her explanation that the result was unintentional and caused by the contamination of a nonprescription medication, melatonin, that Swiatek was taking for issues with jet lag and sleeping.